Mirum Pharmaceuticals, Inc.MIRMNASDAQ
Loading
Operating Income ScalingExpanding
Percentile Rank86
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-22.14M
↑ 74% vs avg
Percentile
P86
Within normal range
Streak
4 yr
Consecutive growthExpanding
Average
$-85.69M
Historical baseline
PeriodValueYoY Change
2025$-22.14M+74.7%
2024$-87.61M+19.7%
2023$-109.15M+16.8%
2022$-131.22M+24.3%
2021$-173.41M-66.3%
2020$-104.30M-90.5%
2019$-54.74M-1777.3%
2018$-2.92M-